Security key
00688A205
Adial Pharmaceuticals, Inc. - Common Stock (ADIL)
CUSIP: 00688A205
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 176,048
- Total 13F value
- $233,389
- Share change
- -88,254
- SEC-reported price per share
- $1.33
- Number of holders
- 13
- Value change
- -$211,877
- Number of buys
- 9
- Number of sells
- 4
- Shares outstanding
- 5,493,768
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
13
Top holders
10
ADIL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
ADIAL PHARMACEUTICALS, INC. SEC filings
ADIAL PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00688A205
Recent filing periods:
Ownership snapshot
Top reported holders of ADIL - Adial Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 2.9%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 2.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
2.9%
Manchester Capital Management LLC
0.88%
RENAISSANCE TECHNOLOGIES LLC
0.42%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.27%
BlackRock Finance, Inc.
0.14%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
2.9%
|
$295,740
159,000 shares
|
— | 31 Dec 2023 |
| Manchester Capital Management LLC |
13F
Company
|
0.88%
|
$89,461
48,097 shares
|
— | 31 Dec 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.42%
|
$43,000
23,200 shares
|
— | 31 Dec 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.27%
|
$27,508
14,789 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
0.14%
|
$14,209
7,639 shares
|
— | 31 Dec 2023 |
| RAFFA WEALTH MANAGEMENT, LLC |
13F
Company
|
0.08%
|
$3,893
2,093 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
176,048
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2025 Across Filers
Q4 2025 holders
22
Q1 2024 holders
13
Holder diff
-9
| Investor | Q4 2025 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend